nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—Diabetic—Octreotide—thymus cancer	0.0671	0.0716	CcSEcCtD
Pioglitazone—Breast feeding—Octreotide—thymus cancer	0.0641	0.0684	CcSEcCtD
Pioglitazone—Ischaemia—Octreotide—thymus cancer	0.0614	0.0655	CcSEcCtD
Pioglitazone—Pregnancy—Octreotide—thymus cancer	0.0395	0.0421	CcSEcCtD
Pioglitazone—Multiple fractures—Octreotide—thymus cancer	0.0386	0.0411	CcSEcCtD
Pioglitazone—Fracture—Octreotide—thymus cancer	0.0386	0.0411	CcSEcCtD
Pioglitazone—Blood creatine phosphokinase increased—Octreotide—thymus cancer	0.0326	0.0347	CcSEcCtD
Pioglitazone—Cramps of lower extremities—Octreotide—thymus cancer	0.0206	0.0219	CcSEcCtD
Pioglitazone—Diabetes mellitus—Octreotide—thymus cancer	0.0187	0.0199	CcSEcCtD
Pioglitazone—Gastroenteritis—Octreotide—thymus cancer	0.0184	0.0196	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Octreotide—thymus cancer	0.0179	0.0191	CcSEcCtD
Pioglitazone—Injury—Octreotide—thymus cancer	0.0177	0.0189	CcSEcCtD
Pioglitazone—Visual disturbance—Octreotide—thymus cancer	0.0172	0.0183	CcSEcCtD
Pioglitazone—Hypoglycaemia—Octreotide—thymus cancer	0.0167	0.0178	CcSEcCtD
Pioglitazone—Pain in extremity—Octreotide—thymus cancer	0.0163	0.0173	CcSEcCtD
Pioglitazone—Abdominal pain upper—Octreotide—thymus cancer	0.0149	0.0158	CcSEcCtD
Pioglitazone—Influenza—Octreotide—thymus cancer	0.0141	0.015	CcSEcCtD
Pioglitazone—Bronchitis—Octreotide—thymus cancer	0.0135	0.0144	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Octreotide—thymus cancer	0.0131	0.0139	CcSEcCtD
Pioglitazone—Weight increased—Octreotide—thymus cancer	0.0128	0.0136	CcSEcCtD
Pioglitazone—Weight decreased—Octreotide—thymus cancer	0.0127	0.0136	CcSEcCtD
Pioglitazone—Hyperglycaemia—Octreotide—thymus cancer	0.0127	0.0135	CcSEcCtD
Pioglitazone—Urinary tract infection—Octreotide—thymus cancer	0.0122	0.013	CcSEcCtD
Pioglitazone—Haematuria—Octreotide—thymus cancer	0.012	0.0127	CcSEcCtD
Pioglitazone—Sinusitis—Octreotide—thymus cancer	0.0118	0.0125	CcSEcCtD
Pioglitazone—Hepatitis—Octreotide—thymus cancer	0.0113	0.012	CcSEcCtD
Pioglitazone—Hypoaesthesia—Octreotide—thymus cancer	0.0112	0.0119	CcSEcCtD
Pioglitazone—Pharyngitis—Octreotide—thymus cancer	0.0112	0.0119	CcSEcCtD
Pioglitazone—Oedema peripheral—Octreotide—thymus cancer	0.0111	0.0118	CcSEcCtD
Pioglitazone—Visual impairment—Octreotide—thymus cancer	0.0108	0.0116	CcSEcCtD
Pioglitazone—Cardiac disorder—Octreotide—thymus cancer	0.0104	0.0111	CcSEcCtD
Pioglitazone—Immune system disorder—Octreotide—thymus cancer	0.0102	0.0108	CcSEcCtD
Pioglitazone—Malnutrition—Octreotide—thymus cancer	0.0098	0.0104	CcSEcCtD
Pioglitazone—Flatulence—Octreotide—thymus cancer	0.00965	0.0103	CcSEcCtD
Pioglitazone—Back pain—Octreotide—thymus cancer	0.00948	0.0101	CcSEcCtD
Pioglitazone—Muscle spasms—Octreotide—thymus cancer	0.00942	0.01	CcSEcCtD
Pioglitazone—Ill-defined disorder—Octreotide—thymus cancer	0.00909	0.00969	CcSEcCtD
Pioglitazone—Anaemia—Octreotide—thymus cancer	0.00905	0.00965	CcSEcCtD
Pioglitazone—Malaise—Octreotide—thymus cancer	0.00883	0.00942	CcSEcCtD
Pioglitazone—Vertigo—Octreotide—thymus cancer	0.0088	0.00938	CcSEcCtD
Pioglitazone—Hypertension—Octreotide—thymus cancer	0.00846	0.00902	CcSEcCtD
Pioglitazone—Myalgia—Octreotide—thymus cancer	0.00834	0.00889	CcSEcCtD
Pioglitazone—Chest pain—Octreotide—thymus cancer	0.00834	0.00889	CcSEcCtD
Pioglitazone—Arthralgia—Octreotide—thymus cancer	0.00834	0.00889	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00828	0.00883	CcSEcCtD
Pioglitazone—Discomfort—Octreotide—thymus cancer	0.00824	0.00878	CcSEcCtD
Pioglitazone—Oedema—Octreotide—thymus cancer	0.008	0.00852	CcSEcCtD
Pioglitazone—Anaphylactic shock—Octreotide—thymus cancer	0.008	0.00852	CcSEcCtD
Pioglitazone—Infection—Octreotide—thymus cancer	0.00794	0.00847	CcSEcCtD
Pioglitazone—Nervous system disorder—Octreotide—thymus cancer	0.00784	0.00836	CcSEcCtD
Pioglitazone—Skin disorder—Octreotide—thymus cancer	0.00777	0.00828	CcSEcCtD
Pioglitazone—Hyperhidrosis—Octreotide—thymus cancer	0.00773	0.00824	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00728	0.00776	CcSEcCtD
Pioglitazone—Insomnia—Octreotide—thymus cancer	0.00723	0.00771	CcSEcCtD
Pioglitazone—Dyspnoea—Octreotide—thymus cancer	0.00713	0.0076	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Octreotide—thymus cancer	0.0069	0.00736	CcSEcCtD
Pioglitazone—Fatigue—Octreotide—thymus cancer	0.00689	0.00735	CcSEcCtD
Pioglitazone—Feeling abnormal—Octreotide—thymus cancer	0.00659	0.00702	CcSEcCtD
Pioglitazone—Urticaria—Octreotide—thymus cancer	0.00635	0.00677	CcSEcCtD
Pioglitazone—Hypersensitivity—Octreotide—thymus cancer	0.00589	0.00628	CcSEcCtD
Pioglitazone—Asthenia—Octreotide—thymus cancer	0.00574	0.00611	CcSEcCtD
Pioglitazone—SLCO1B3—pituitary gland—thymus cancer	0.00571	0.0924	CbGeAlD
Pioglitazone—Diarrhoea—Octreotide—thymus cancer	0.00547	0.00583	CcSEcCtD
Pioglitazone—Dizziness—Octreotide—thymus cancer	0.00529	0.00564	CcSEcCtD
Pioglitazone—PPARG—neck—thymus cancer	0.00516	0.0834	CbGeAlD
Pioglitazone—Headache—Octreotide—thymus cancer	0.00501	0.00534	CcSEcCtD
Pioglitazone—SLCO1B3—lung—thymus cancer	0.00447	0.0723	CbGeAlD
Pioglitazone—SLCO1B1—hematopoietic system—thymus cancer	0.00445	0.072	CbGeAlD
Pioglitazone—PPARG—hematopoietic system—thymus cancer	0.00384	0.0621	CbGeAlD
Pioglitazone—PPARG—epithelium—thymus cancer	0.00351	0.0568	CbGeAlD
Pioglitazone—CYP2C19—hematopoietic system—thymus cancer	0.0029	0.0469	CbGeAlD
Pioglitazone—PPARG—lymphoid tissue—thymus cancer	0.0027	0.0437	CbGeAlD
Pioglitazone—CYP2C8—hematopoietic system—thymus cancer	0.00253	0.0409	CbGeAlD
Pioglitazone—PPARG—bone marrow—thymus cancer	0.00246	0.0398	CbGeAlD
Pioglitazone—PPARG—thyroid gland—thymus cancer	0.00246	0.0397	CbGeAlD
Pioglitazone—CYP2C9—hematopoietic system—thymus cancer	0.00225	0.0364	CbGeAlD
Pioglitazone—PPARG—lung—thymus cancer	0.00223	0.0361	CbGeAlD
Pioglitazone—PTGS1—hematopoietic system—thymus cancer	0.00205	0.0332	CbGeAlD
Pioglitazone—CYP2C8—pituitary gland—thymus cancer	0.00188	0.0304	CbGeAlD
Pioglitazone—PTGS1—epithelium—thymus cancer	0.00188	0.0304	CbGeAlD
Pioglitazone—CYP3A4—hematopoietic system—thymus cancer	0.00172	0.0277	CbGeAlD
Pioglitazone—CYP2D6—hematopoietic system—thymus cancer	0.00169	0.0273	CbGeAlD
Pioglitazone—PTGS1—cardiac atrium—thymus cancer	0.00156	0.0252	CbGeAlD
Pioglitazone—PPARG—lymph node—thymus cancer	0.00153	0.0247	CbGeAlD
Pioglitazone—PTGS1—pituitary gland—thymus cancer	0.00152	0.0246	CbGeAlD
Pioglitazone—PTGS1—thyroid gland—thymus cancer	0.00131	0.0212	CbGeAlD
Pioglitazone—PTGS1—lung—thymus cancer	0.00119	0.0193	CbGeAlD
Pioglitazone—PTGS1—lymph node—thymus cancer	0.000816	0.0132	CbGeAlD
